A critical evaluation of microcalorimetry as a predictive tool for long term stability of liquid protein formulations: granulocyte colony stimulating factor (GCSF).

Microcalorimetry is frequently used as a high throughput predictive method in order to screen different formulations for their storage stability. However, the predictive power of measuring unfolding temperatures (Tm), although studied for the stability of proteins under stress, has not been investigated systematically for long term stability of pharmaceutical proteins yet. In this study, the microcalorimetric Tm is evaluated as a predictive tool for long term stability of 24 liquid formulations of Granulocyte Colony Stimulating Factor. Those were tested with respect to the effect of different buffer salts in different concentrations, different pH values, and the effect of two excipients: polysorbate 80 and hydroxy propyl-β-Cyclodextrin. Formulations were first ranked based on the measured Tm. The same formulations were then ranked based on a long term stability study at 2-8 °C for a period of up to 24 months. For this study, standard analytical methods were used to assess both physical and chemical stabilities of the formulations on long term. Microcalorimetric Tm based ranking was then compared with the long term stability ranking. Determining Tm turned out to be a successful predictive tool to select good formulations and exclude bad ones with an acceptable low degree of error. In particular, physical long term stability at a storage temperature of 2-8 °C was better predicted by just measuring Tm than by conducting stress studies at elevated temperatures.

[1]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[2]  Somnath Singh,et al.  Effect of polyols on the conformational stability and biological activity of a model protein lysozyme , 2003, AAPS PharmSciTech.

[3]  Theodore W Randolph,et al.  Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony‐stimulating factor , 2003, Protein science : a publication of the Protein Society.

[4]  S. Charman,et al.  Techniques for Assessing the Effects of Pharmaceutical Excipients on the Aggregation of Porcine Growth Hormone , 1993, Pharmaceutical Research.

[5]  M. Llabrés,et al.  New approach to stability assessment of protein solution formulations by differential scanning calorimetry. , 2003, International journal of pharmaceutics.

[6]  K. Uekama,et al.  Cyclodextrins in peptide and protein delivery. , 1999, Advanced drug delivery reviews.

[7]  C. Kolvenbach,et al.  Granulocyte‐colony stimulating factor maintains a thermally stable, compact, partially folded structure at pH 2 , 2009 .

[8]  Wayne R. Gombotz,et al.  Interleukin-1 Receptor (IL-1R) Liquid Formulation Development Using Differential Scanning Calorimetry , 1998, Pharmaceutical Research.

[9]  Structural characterization of bovine granulocyte colony stimulating factor: effect of temperature and pH. , 2003, Journal of pharmaceutical sciences.

[10]  Theodore W Randolph,et al.  Aggregation of recombinant human botulinum protein antigen serotype C in varying solution conditions: implications of conformational stability for aggregation kinetics. , 2011, Journal of pharmaceutical sciences.

[11]  F. Avilés,et al.  Influence of aggregation propensity and stability on amyloid fibril formation as studied by Fourier transform infrared spectroscopy and two-dimensional COS analysis. , 2009, Biochemistry.

[12]  Daniel I. C. Wang,et al.  Effects of Excipients on the Hydrogen Peroxide-Induced Oxidation of Methionine Residues in Granulocyte Colony-Stimulating Factor , 2004, Pharmaceutical Research.

[13]  T. Palm,et al.  The effect of PEGylation on the stability of small therapeutic proteins , 2011, Pharmaceutical development and technology.

[14]  Jagdish Singh,et al.  Lysozyme Stability in Primary Emulsion for PLGA Microsphere Preparation: Effect of Recovery Methods and Stabilizing Excipients , 2002, Pharmaceutical Research.

[15]  R. Forbes,et al.  Study of protein conformational stability and integrity using calorimetry and FT-Raman spectroscopy correlated with enzymatic activity. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  T. Johnston.  Adsorption of recombinant human granulocyte colony stimulating factor (rhG-CSF) to polyvinyl chloride, polypropylene, and glass: effect of solvent additives. , 1996, PDA journal of pharmaceutical science and technology.

[17]  S. Ausar,et al.  High-throughput screening of stabilizers for Respiratory Syncytial Virus: Identification of stabilizers and their effects on the conformational thermostability of viral particles , 2007, Human vaccines.

[18]  Hanns-Christian Mahler,et al.  Forced degradation of therapeutic proteins. , 2012, Journal of pharmaceutical sciences.

[19]  Sara Linse,et al.  Salting the charged surface: pH and salt dependence of protein G B1 stability. , 2006, Biophysical journal.

[20]  Theodore W Randolph,et al.  Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition. , 2002, Biochemistry.

[21]  J L Cleland,et al.  Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. , 1998, Journal of pharmaceutical sciences.

[22]  D. Lauffenburger,et al.  pH Dependence of structural stability of interleukin‐2 and granulocyte colony‐stimulating factor , 2003, Protein science : a publication of the Protein Society.

[23]  M. M. Kristjánsson,et al.  Protein and enzyme stability: structural, thermodynamic, and experimental aspects. , 1991, Advances in food and nutrition research.

[24]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[25]  W. Gombotz,et al.  Minimization of recombinant human Flt3 ligand aggregation at the Tm plateau: a matter of thermal reversibility. , 1999, Biochemistry.

[26]  C. O. Fágáin,et al.  Understanding and increasing protein stability. , 1995, Biochimica et biophysica acta.

[27]  Theodore W Randolph,et al.  Surfactant-protein interactions. , 2002, Pharmaceutical biotechnology.

[28]  L. Margulis,et al.  Aggregation of Recombinant Bovine Granulocyte Colony Stimulating Factor in Solution , 2002, Journal of protein chemistry.

[29]  T. Boone,et al.  Characterization, formulation, and stability of Neupogen (Filgrastim), a recombinant human granulocyte-colony stimulating factor. , 1996, Pharmaceutical biotechnology.

[30]  D. Brems,et al.  Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor. , 2006, Journal of pharmaceutical sciences.

[31]  W. Friess,et al.  A Critical Evaluation of Tm(FTIR) Measurements of High-Concentration IgG1 Antibody Formulations as a Formulation Development Tool , 2006, Pharmaceutical Research.

[32]  Bernhardt L Trout,et al.  Comparative oxidation studies of methionine residues reflect a structural effect on chemical kinetics in rhG-CSF. , 2006, Biochemistry.

[33]  R. Jaenicke,et al.  Protein stability and molecular adaptation to extreme conditions. , 1991, European journal of biochemistry.

[34]  A. Cooper,et al.  Energetics of cyclodextrin-induced dissociation of insulin , 1996, European Biophysics Journal.